All reports

Evaluation of breast cancer screening in Belgium

KCE Reports 423C (2026)

Screening for PFAS exposure in humans

KCE Rapid Response Reports (R³) 403C (2025)This report is only available in French and Dutch. We apologise for the inconvenience.

Survival and Quality of care offered in Belgian hospitals with and without recognition for breast cancer

KCE Reports 365C (2023)

The right to be forgotten in breast cancer: new propositions

KCE Reports 351C (2022)

MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

KCE Reports 298C (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy.

Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment

KCE Reports 237C (2015)

Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

KCE Reports 236C (2015)

Informed choice on breast cancer screening: messages to support informed decision

KCE Reports 216C (2014)

Breast cancer in women: diagnosis, treatment and follow-up

KCE Reports 143C (2013)

Breast cancer screening amongst women aged 70-74 years of age

KCE Reports 176C (2012)

[Identifying women at risk for breast cancer/technical methods for breast cancer screening]

KCE Reports 172 (2012)

Quality indicators in oncology: breast cancer

KCE Reports 150C (2010)

[Breast cancer screening with mammography for women in the agegroup of 40-49 years]

KCE Reports 129 (2010)KCE Report 129 is no longer available for download, but can be obtained on request via the ‘contact’ section.Please see the updated version of this report (09/07/2026): KCE Reports 423C Evaluation of breast cancer screening in Belgium

Trastuzumab in Early Stage Breast Cancer

KCE Reports 34C (2006)30 June (2nd edition; 22 June 2006, 1st edition)

[Breast cancer screening]

KCE Reports 11 (2005)KCE Report 11 is no longer available for download, but can be obtained on request via the ‘contact’ section.Please see the updated version of this report (09/07/2026): KCE Reports 423C Evaluation of breast cancer screening in Belgium

You are here

All reports

General domain

Publication year

Results

15 results

Evaluation of breast cancer screening in Belgium

Screening for PFAS exposure in humans

Survival and Quality of care offered in Belgian hospitals with and without recognition for breast cancer

The right to be forgotten in breast cancer: new propositions

MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment

Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

Informed choice on breast cancer screening: messages to support informed decision

Breast cancer in women: diagnosis, treatment and follow-up

Breast cancer screening amongst women aged 70-74 years of age

[Identifying women at risk for breast cancer/technical methods for breast cancer screening]

Quality indicators in oncology: breast cancer

[Breast cancer screening with mammography for women in the agegroup of 40-49 years]

Trastuzumab in Early Stage Breast Cancer

[Breast cancer screening]